Avadel Pharmaceuticals plc (NASDAQ: AVDL)
$11.3100
+0.5600 ( +5.31% ) 449.4K
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
Market Data
Open
$11.3100
Previous close
$10.7500
Volume
449.4K
Market cap
$1.06B
Day range
$10.6780 - $11.5600
52 week range
$10.4100 - $19.0900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Nov 12, 2024 |
10-q | Quarterly Reports | 67 | Nov 12, 2024 |
8-k | 8K-related | 14 | Oct 31, 2024 |
8-k | 8K-related | 19 | Oct 17, 2024 |
4 | Insider transactions | 1 | Sep 16, 2024 |
4 | Insider transactions | 1 | Sep 13, 2024 |
8-k | 8K-related | 13 | Sep 12, 2024 |
8-k | 8K-related | 13 | Aug 28, 2024 |
10-q | Quarterly Reports | 66 | Aug 08, 2024 |
8-k | 8K-related | 14 | Aug 08, 2024 |